Completed PHASE1 INTERVENTIONAL 3-arm NCT03720678

A Study to Evaluate Immunotherapy Combinations in Participants With Gastrointestinal Malignancies

A Phase 1/1b Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Gastrointestinal Malignancies

Sponsor: Arcus Biosciences, Inc.

Conditions Colorectal Cancer GastroEsophageal Cancer

Interventions etrumadenant mFOLFOX

Updated 25 times since 2018 Last updated: May 23, 2024 Started: Nov 18, 2018 Primary completion: Jan 27, 2021 Completion: Jun 25, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Colorectal Cancer and GastroEsophageal Cancer and is currently completed. Arcus Biosciences, Inc. leads this study, which shows 25 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

25 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jun 2024 — Jul 2024 [monthly]

Completed PHASE1
Sep 2023 — Jun 2024 [monthly]

Completed PHASE1
Jan 2023 — Sep 2023 [monthly]

Completed PHASE1

▶ Show 20 earlier versions

Nov 2022 — Jan 2023 [monthly]

Completed PHASE1
Jun 2022 — Nov 2022 [monthly]

Completed PHASE1
May 2022 — Jun 2022 [monthly]

Completed PHASE1
Apr 2022 — May 2022 [monthly]

Completed PHASE1
Sep 2021 — Apr 2022 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed
Jun 2021 — Sep 2021 [monthly]

Active Not Recruiting PHASE1
May 2021 — Jun 2021 [monthly]

Active Not Recruiting PHASE1
Mar 2021 — May 2021 [monthly]

Active Not Recruiting PHASE1
Jan 2021 — Mar 2021 [monthly]

Active Not Recruiting PHASE1
Oct 2020 — Jan 2021 [monthly]

Active Not Recruiting PHASE1
Aug 2020 — Oct 2020 [monthly]

Active Not Recruiting PHASE1
Jul 2020 — Aug 2020 [monthly]

Active Not Recruiting PHASE1

Status: Recruiting → Active Not Recruiting
Apr 2020 — Jul 2020 [monthly]

Recruiting PHASE1
Dec 2019 — Apr 2020 [monthly]

Recruiting PHASE1
Nov 2019 — Dec 2019 [monthly]

Recruiting PHASE1
Sep 2019 — Nov 2019 [monthly]

Recruiting PHASE1
Apr 2019 — Sep 2019 [monthly]

Recruiting PHASE1
Jan 2019 — Apr 2019 [monthly]

Recruiting PHASE1
Dec 2018 — Jan 2019 [monthly]

Recruiting PHASE1
Nov 2018 — Dec 2018 [monthly]

Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Arcus Biosciences, Inc.

Data source: Arcus Biosciences, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albury, Australia , Austin, United States , Boston, United States , Camperdown, Australia , Dallas, United States , Darlinghurst, Australia , Denver, United States , Fairfax, United States , Farmington Hills, United States , Fort Worth, United States and 13 more locations